NLRP3 and kidney disorder: Oral or intravenous infusion of EGCG could reduce mRNA and protein expression of renal NLRP3 in lupus nephritis mouse model and contrast-induced nephropathy rat model, possibly leading to the reduction of NLRP3 inflammasome activation [61,72].